Fairfield, Bush & Co’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$264K Buy
1,253
+30
+2% +$6.02K 0.12% 112
2026
Q2
$233K Buy
+1,223
New +$210K 0.11% 117
2026
Q1
– Sell
-1,353
Closed -$228K – 122
2025
Q4
$228K Buy
+1,353
New +$220K 0.12% 107
2024
Q1
– Sell
-793
Closed -$108K – 263
2023
Q4
$108K Buy
+793
New +$96.8K 0.06% 144
2023
Q3
– Sell
-118
Closed -$15K – 277
2023
Q2
$15K Buy
+118
New +$15.3K ﹤0.01% 288
2022
Q3
– Sell
-159
Closed -$19K – 260
2022
Q2
$19K Buy
+159
New +$18.9K 0.01% 261

Other funds holding IBB

Fairfield, Bush & Co's IBB Position: Q3 2026 in Review

Fairfield, Bush & Co increased its iShares Biotechnology ETF (IBB) stake by 2.5% in Q3 2026, buying an estimated $6.02K and bringing the position to 1,253 shares worth $264K. The position accounts for 0.12% of the portfolio, ranked #112.

Fairfield, Bush & Co first reported a position in IBB in Q2 2022 and has held it in 6 quarters since. 957 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Fairfield, Bush & Co held 1,253 shares of iShares Biotechnology ETF worth $264K as of Q3 2026.
  • Fairfield, Bush & Co bought 30 iShares Biotechnology ETF shares in Q3 2026, an estimated $6.02K.
  • iShares Biotechnology ETF made up 0.12% of Fairfield, Bush & Co's portfolio in Q3 2026, its #112 holding.
  • Fairfield, Bush & Co first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 6 quarters since.
  • 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Fairfield, Bush & Co's 13F filing for Q3 2026, filed 13 Nov 2026.